000 05279cam a2200409Ii 4500
001 95910
003 ES-MaUEC
005 20230102112728.0
006 m o d
007 cr cnu|||unuuu
008 170502s2017 sz a o 000 0 eng d
020 _a3319418521
_q(electronic bk.)
020 _a9783319418520
_q(electronic bk.)
020 _z3319418505
020 _z9783319418506
_q(print)
040 _aN$T
_cN$T
_dEBLCP
_dGW5XE
_dYDX
_dN$T
_dUAB
_dMERER
_dESU
_dAZU
_dUPM
_dOCLCF
_dCOO
_dOCLCO
_dOCLCQ
_dOCLCO
_dOTZ
_dVT2
_dOCLCQ
_dIOG
_dOCLCO
_dOCLCQ
_dU3W
_dOCLCO
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRC776.R38
_b2017 EB
245 0 0 _aAcute respiratory distress syndrome
_cDavide Chiumello, editor.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea (vi, 360 páginas)
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
504 _aIncluye referencias bibliográficas
505 0 _a1: Acute Respiratory Distress Syndrome (ARDS): Definition, Incidence, and Outcome; 1.1 Definition of ARDS; 1.1.1 From the First Clinical Description to the First Consensus Definition of ARDS; 1.1.2 The Current Berlin Definition; 1.1.3 What Are the Limitations of the Current Definition?; 1.2 Incidence and Outcome of ARDS; 1.2.1 Has Mortality Decreased Over Time?; 1.2.2 How Can We Explain the Lack of Improvement in Outcome in ARDS?; 1.2.3 Causes of Death and Subphenotypes in Patients with ARDS; 1.2.4 Long-Term Outcome; References.
505 8 _a2: Pathophysiology of Acute Respiratory Distress Syndrome2.1 Introduction; 2.2 Pathophysiology of Acute Respiratory Distress Syndrome: The Actors; 2.2.1 Alveolar Macrophages; 2.2.2 Neutrophils; 2.2.3 Alveolar Epithelium; 2.2.4 Alveolar Endothelium; 2.3 Pulmonary Versus Extrapulmonary ARDS: The Myth Is a Fact; 2.4 ARDS Phenotypes; 2.4.1 Septic and Cancer Phenotypes; 2.4.2 Trauma and Transfusion Phenotypes; 2.5 Future Perspectives for Translation of Experimental Models into Therapy; References; 3: Ventilation Strategies: Tidal Volume and PEEP; 3.1 Introduction.
505 8 _a3.2 Respiratory System Structural Dysfunction After ARDS3.3 Tidal Volume and PEEP During Spontaneous Ventilatory Support in ARDS Patients; 3.4 Invasive Mechanical Ventilation in ARDS Patients: Role of Tidal Volume; 3.5 Limiting the Tidal Volumes in ARDS with Modern Ventilators; 3.6 Low Tidal Volumes Must Generate Low Driving Pressures to Assure It Is Really Protective to ARDS Patients; 3.7 Invasive Mechanical Ventilation in ARDS Patients: Role of End-Positive Expiratory Pressure (PEEP) Levels.
505 8 _a3.8 Interaction Between Low Tidal Volume and High PEEP Levels During Invasive Mechanical Ventilation in ARDS PatientsReferences; 4: Ventilation Strategies: High-Frequency Oscillatory Ventilation; 4.1 Introduction; 4.2 Mechanisms of Gas Transport and Exchange; 4.2.1 Bulk Convection; 4.2.2 Molecular Diffusion; 4.2.3 Asymmetric Velocity Profiles; 4.2.4 Taylor Dispersion; 4.2.5 Pendelluft Phenomena; 4.2.6 Cardiogenic Mixing; 4.2.7 Collateral Ventilation; 4.3 Principles of Non-injurious Mechanical Ventilation and HFOV Settings; 4.3.1 Protection of the Lungs; 4.3.2 Protection of the RV.
505 8 _a4.4 Complications of HFOV4.5 Adjunctive Therapies to HFOV; 4.6 Clinical Evidence for the Use of HFOV; References; 5: Ventilation Strategies: Recruitment Maneuvers; 5.1 Introduction; 5.2 Physiology of Recruitment Maneuvers; 5.2.1 Definition and Rationale; 5.2.2 Consequences and Safety; 5.3 Techniques of Recruitment Maneuvers; 5.3.1 Sigh; 5.3.2 Sustained Inflation; 5.3.3 Slow Stepwise Maneuvers; 5.4 Evaluation of Recruitment Maneuver Effects; 5.4.1 Blood Gas Analysis and PaO2/FiO2 Ratio; 5.4.2 Compliance and Pressure-Volume Curve; 5.4.3 Computed Tomography; 5.4.4 Lung Ultrasound.
520 3 _aThis book covers all clinical aspects of acute respiratory distress syndrome (ARDS), from definition to treatment, focusing on the more recent recommendations and evidence-based medicine. The addressed topics are the various ventilation strategies, the impact of prone positioning, the use of partial and total extracorporeal support, the value of vasodilators, the weaning from mechanical ventilation, the pharmacological interventions, noninvasive ventilation, and the strategies using anti-inflammatory agents and stem cells. Furthermore, different related topics are also discussed, such as lung imaging, sedation, metabolic support, and hemodynamic instability. A concluding chapter specifically addresses ARDS in children. This up-to-date volume, written by experts in the field, will be of value for all health care practitioners seeking state of the art on the management of patients with this complex syndrome.
650 7 _aInsuficiencia respiratoria
_2embne
_0(OCoLC)fst01095734
_0
_9145481
700 1 _aChiumello, Davide,
_eeditor literario
_995331
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-41852-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95910
_d95910
_x1